Consequences of peripheral vasculopathy, including Raynaud’s phenomenon, were being noticed in postmarketing stories and for the therapeutic dosages of CNS stimulants in all age groups all through the system of therapy. Signs and indications generally improved just after dosage reduction or discontinuation of your CNS stimulant.The equilibrium co